sutures newsletter


FDA Warns About Extended-Release Opioid Products

Pharmacy Focus

The federal Food and Drug Administration has added a boxed warning to long-acting extended-release opioid products, noting an increased risk of opioid addiction, abuse and misuse, potentially leading to overdose and death. Serious, life-threatening or fatal respiratory depression may occur.

Mark Your Calendar

Surgery Grand Rounds

Click the "read more" to see information about upcoming Surgery Grand Rounds.

Grand Rounds

Click here to view a schedule of all upcoming grand rounds.

Educational Schedule

Click a PDF link below to see the Department of Surgery's educational schedule.

Educational Schedule - October 2014 (PDF)

Educational Schedule - November 2014 (PDF)

Surgery Scheduling

Click the "read more" for hours and contact information for surgery scheduling.

Share Your News

Know an interesting colleague we should profile? A story we should tell? Submit your ideas, meetings and events for consideration.

Click here to submit your news to Sutures

Surgery Grand Rounds

  • Wednesday, Oct. 29, 7-8 a.m., ECC A-B — Everything You Wanted to Know About Lower Extremity Fractures but Were Afraid to Ask, by Donald A. Wiss, MD, director of the Cedars-Sinai Orthopaedic Trauma Program
  • Wednesday, Nov. 12, 7-8 a.m., Advanced Health Sciences Pavilion, PEC 4-5 — Immune System vs. Cancer, by Hyung Lae Kim, MD, director of Academic Programs, Cedars-Sinai Urology, associate director of Surgical Research, Samuel Oschin Comprehensive Cancer Institute, and co-medical director of the Urologic Oncology Program
  • Wednesday, Nov. 19, 7-8 a.m., ECC-B — Effective Healthcare Providing in the 21st Century (How to Work Through Stress and Burnout, and Continue to Heal Patients), by Waguih William IsHak, MD, vice chair of Education and Research and consultant psychiatrist, Cedars-Sinai Psychiatry and Behavioral Neurosciences
  • Wednesday, Nov. 26, 7-8 a.m., ECC B-C — Advances in Heart Transplantation, by Jon Kobashigawa, MD, associate director of Clinical Affairs, Cedars-Sinai Heart Institute, director of Advanced Heart Disease, director of the Heart Transplant Program, and DSL/Thomas D. Gordon Chair in Heart Transplantation Medicine